Author(s): Cody Paiva, Taylor Rowland, Bhargava Sreekantham, et. al. Abstract: S 118 Session topic: 5. Chronic lymphocytic leukemia and related disorders – Biology Background: Although small molecule inhibitors of BCR-associated kinases (BCRi) revolutionized therapy in CLL, they provide incomplete responses. Tumor necrosis factor receptor superfamily ligands BAFF and APRIL induce NFκB, which...
Pro zobrazení tohoto obsahu je třeba být přihlášen.